Document Mentions (3 shared documents)

EFTA02686169

3 mentions1 same-page

Page ?Same page

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

Spain Beat Balzli Editor-in-Chief HandelsZeitung and Switzerland Finanzrundschau AG Ban Ki-moon Secretary-General, United Nations, New York Stephan Bancel Chief Executive Officer bioMerieux SA USA Oriana Bandiera Professor of Economics London School of United Kingdom Economics and Political Sci

EFTA02686246

3 mentions1 same-page

Page ?Same page

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

EFTA00136746

2 mentions1 same-page

Page ?Same page

orn/2020/09/30/us/elections/with-remarlcs- about-poll-watchers-and-the-supreme-court-trump-stepped-up-attempts-to-sow-doubt-on-the-vote.html> (9/30, Epstein, Thrush, 18.61 M) says that "in recent months, as his standing in the polls has fallen, Mr. Trump has pre- emptively argued that Democratic elections

ios <https://www.axios.cornimodema-ceo-coronavirus-vaccine-2021-4ea78750-8aab-497a-blle- d8771630f3e8.html> (9/30, Knutson, 521K) reports Moderna CEO Stephan Bancel said Wednesday that his company's coronavirus vaccine "won't be available for widespread distribution until at least spring 2021." Bancel said the